Skip to main content
Clinical Trials/CTRI/2023/05/052259
CTRI/2023/05/052259
Recruiting
Phase 2

Randomised Controlled Clinical Study of Efficacy of Nisha-Amalaki Churna on Insulin Resistance in Overweight subjects with special reference to Sthaulya

Shivani Vinayak Shete0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shivani Vinayak Shete
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Shivani Vinayak Shete

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who are fulfilling above mentioned diagnostic criteria
  • 2\. Patients who are willing for treatment
  • 3\. Patients irrespective of their sex, religion and socioeconomic status.
  • 4\. Patients between age group 18\-60
  • 5\. BMI 23 TO 35

Exclusion Criteria

  • 1\. Patients with chronic alcoholism
  • 2\. Patients with infectious disorder
  • 3\. Patients with multiple drug therapy/steroids
  • 4\. Pregnant or lactating women
  • 5\. Critically ill patients
  • 6\. Patients having clinical condition which may interact with either insulin levels or drug action

Outcomes

Primary Outcomes

Not specified

Similar Trials